HCA Midwest — Kansas City, Missouri

HCA Midwest is a clinical research site located in Kansas City, Missouri, United States 64132.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

HCA Midwest has participated in 6 clinical trials with 1 currently active.

Therapeutic areas: Endometrial Adenocarcinoma, Metastatic Breast Cancer, Degenerative Sacroiliitis.

Sponsors: Acrivon Therapeutics, Eli Lilly and Company, SI-BONE, Inc..

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for HCA Midwest?

HCA Midwest has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has HCA Midwest conducted?

HCA Midwest has 6 clinical trials on record, with 1 currently active. Their work covers Endometrial Adenocarcinoma, Metastatic Breast Cancer, Degenerative Sacroiliitis.

Is HCA Midwest accredited by Crixeo Health?

Yes — HCA Midwest holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about HCA Midwest?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.